One of the Best “SynBio” Stocks Now

Synthetic biology (“synbio”) giant Moderna (MRNA) could soon surge higher…

Over the past six months, shares of MRNA have plummeted by nearly 58%. This is primarily due to the recent sell-off of growth stocks across the market. 

However, reports that COVID-19’s Omicron variant was less severe than other strains didn’t help the synbio firm, either…

When the Omicron variant first emerged, it immediately fueled similar fears brought on by prior versions of COVID-19. 

But when data from South Africa and other parts of the world came out showing it spread faster – but created far fewer symptoms – consumers and investors became less concerned. 

And when you couple that with the world’s shift in focus to the Russia-Ukraine crisis, COVID-19-related news also fell by the wayside. 

Even so, the emergence of yet another strain could ultimately bring investors back to this synbio stock…

Over the past several days, reports of a new strain – now referred to as “Deltacron” – suggest the virus won’t be going away anytime soon. 

And it even forced the Chinese government to once again enter a renewed lockdown to prevent its rapid spread, indicating the world will likely remain reliant on MRNA’s vaccines for years to come.

This was made abundantly clear following MRNA’s most recent earnings report as well…

In late-February, the synbio company reported earnings per share of $11.29, beating Wall Street’s estimates of $9.96. 

Meanwhile, MRNA’s revenue of $7.21 billion also came in well above the expectation of $6.8 billion – signaling demand for its vaccines and other mRNA-based treatments remains elevated. 

And with many health experts forecasting COVID-19 strains becoming endemic like the flu, this demand for updated vaccines from synbio companies like MRNA will continue over the long term.

Do you know Steve Jobs' “Final Prophecy?”

Sponsored

In his biography, just before he died, Apple founder Steve Jobs issued a “Final Prophecy.”

This was back in 2011.

At the time, Jobs' prediction didn't get much attention – in fact, I think few actually understood what he meant.

But today, with so many digital technology stocks crashing all around us, it's becoming more and more clear that Steve Jobs' “Final Prophecy” is coming to life RIGHT NOW.

Keep in mind, this was the guy who accurately predicted the Internet, laptop computers, Siri and Alexa voice assistants, e-commerce, and cloud computing, just to name a few… long before these things were a blip on the radar.

As Walter Isaacson, Jobs' biographer, says:

And that's exactly why today I want to tell you about Steve Jobs' “Final Prophecy” – because it is coming to life right now… And more importantly, I believe it will result in by far the biggest investment gains in the world over the next decade.

So… for the next few minutes… forget the technologies dominating today's headlines…

Forget cryptocurrencies, 5G, electric vehicles, and self-driving cars. Forget the blockchain, quantum computing, artificial intelligence, and virtual reality. Forget NFTs, apps, space exploration, and cloud computing.

I want to show you something totally new and radically different.

I think you're going to be blown away by this – it truly is incredible.

All the details are in my brand-new presentation, which I just posted on my company's website. You can access it totally free of charge, right here

P.S. I almost forgot to tell you…

In my new presentation I also reveal my #1 favorite stock to take advantage of Steve Jobs' “Final Prophecy,” right now. It's an incredible business I think you can probably buy and hold for the next decade or more. The profit potential is enormous. No e-mail, subscription, or credit card required to get my #1 pick.

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works